N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile

C111H129F3N26O8 — CID 157188437

IUPACN-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile
SMILESCOc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2CCCN(C(C)C)C2)c1
InChIInChI=1S/C29H33F3N6O2.C28H35N7O2.C28H34N6O2.C26H27N7O2/c1-36-19-20(17-34-36)28-18-33-26-6-5-22(15-27(26)35-28)38(23-13-24(39-2)16-25(14-23)40-3)10-4-9-37-11-7-21(8-12-37)29(30,31)32;1-32(2)22-8-9-34(19-22)10-11-35(23-12-24(36-4)15-25(13-23)37-5)21-6-7-26-27(14-21)31-28(17-29-26)20-16-30-33(3)18-20;1-19(2)33-10-6-7-22(18-33)34(23-11-24(35-4)14-25(12-23)36-5)21-8-9-26-27(13-21)31-28(16-29-26)20-15-30-32(3)17-20;1-34-22-9-21(10-23(12-22)35-2)33(8-7-32-6-5-18(13-27)17-32)20-3-4-24-25(11-20)31-26(16-28-24)19-14-29-30-15-19/h5-6,13-19,21H,4,7-12H2,1-3H3;6-7,12-18,22H,8-11,19H2,1-5H3;8-9,11-17,19,22H,6-7,10,18H2,1-5H3;3-4,9-12,14-16,18H,5-8,17H2,1-2H3,(H,29,30)/t;;;18-/m...1/s1
InChIKeyAPKFNXGIDUFFAU-VQSBLDOUSA-N
MW2012.42 g/mol
LogP18.75
Rot. Bonds33

About N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile

N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile (PubChem CID 157188437) has the molecular formula C111H129F3N26O8 and a molecular weight of 2012.42 g/mol. Its IUPAC name is N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile.

Molecular Properties

Compound NameN-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile
PubChem CID157188437
Molecular FormulaC111H129F3N26O8
Molecular Weight2012.42 g/mol
Exact Mass2011.04
IUPAC NameN-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile
SMILESCOc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2CCCN(C(C)C)C2)c1
InChIInChI=1S/C29H33F3N6O2.C28H35N7O2.C28H34N6O2.C26H27N7O2/c1-36-19-20(17-34-36)28-18-33-26-6-5-22(15-27(26)35-28)38(23-13-24(39-2)16-25(14-23)40-3)10-4-9-37-11-7-21(8-12-37)29(30,31)32;1-32(2)22-8-9-34(19-22)10-11-35(23-12-24(36-4)15-25(13-23)37-5)21-6-7-26-27(14-21)31-28(17-29-26)20-16-30-33(3)18-20;1-19(2)33-10-6-7-22(18-33)34(23-11-24(35-4)14-25(12-23)36-5)21-8-9-26-27(13-21)31-28(16-29-26)20-15-30-32(3)17-20;1-34-22-9-21(10-23(12-22)35-2)33(8-7-32-6-5-18(13-27)17-32)20-3-4-24-25(11-20)31-26(16-28-24)19-14-29-30-15-19/h5-6,13-19,21H,4,7-12H2,1-3H3;6-7,12-18,22H,8-11,19H2,1-5H3;8-9,11-17,19,22H,6-7,10,18H2,1-5H3;3-4,9-12,14-16,18H,5-8,17H2,1-2H3,(H,29,30)/t;;;18-/m...1/s1
InChIKeyAPKFNXGIDUFFAU-VQSBLDOUSA-N
XLogP18.75
TPSA312.05 Ų
H-Bond Donors1
H-Bond Acceptors33
Rotatable Bonds33
Heavy Atoms148
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002012.42
LogP ≤ 518.75
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1033

Analyze N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile?
The IUPAC name of N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile (CID 157188437) is N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile.
What is the SMILES notation for N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile?
The canonical SMILES for N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile is COc1cc(OC)cc(N(CCCN2CCC(C(F)(F)F)CC2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCN2CCC(N(C)C)C2)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCN2CC[C@H](C#N)C2)c2ccc3ncc(-c4cn[nH]c4)nc3c2)c1.COc1cc(OC)cc(N(c2ccc3ncc(-c4cnn(C)c4)nc3c2)C2CCCN(C(C)C)C2)c1.
What is the InChIKey of N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile?
The InChIKey is APKFNXGIDUFFAU-VQSBLDOUSA-N. The full InChI is InChI=1S/C29H33F3N6O2.C28H35N7O2.C28H34N6O2.C26H27N7O2/c1-36-19-20(17-34-36)28-18-33-26-6-5-22(15-27(26)35-28)38(23-13-24(39-2)16-25(14-23)40-3)10-4-9-37-11-7-21(8-12-37)29(30,31)32;1-32(2)22-8-9-34(19-22)10-11-35(23-12-24(36-4)15-25(13-23)37-5)21-6-7-26-27(14-21)31-28(17-29-26)20-16-30-33(3)18-20;1-19(2)33-10-6-7-22(18-33)34(23-11-24(35-4)14-25(12-23)36-5)21-8-9-26-27(13-21)31-28(16-29-26)20-15-30-32(3)17-20;1-34-22-9-21(10-23(12-22)35-2)33(8-7-32-6-5-18(13-27)17-32)20-3-4-24-25(11-20)31-26(16-28-24)19-14-29-30-15-19/h5-6,13-19,21H,4,7-12H2,1-3H3;6-7,12-18,22H,8-11,19H2,1-5H3;8-9,11-17,19,22H,6-7,10,18H2,1-5H3;3-4,9-12,14-16,18H,5-8,17H2,1-2H3,(H,29,30)/t;;;18-/m...1/s1.
What are the key properties of N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile?
N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile has a molecular weight of 2012.42 g/mol, XLogP of 18.75, 33 rotatable bonds, 1 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3,5-dimethoxyphenyl)-N-[2-[3-(dimethylamino)pyrrolidin-1-yl]ethyl]-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(1-propan-2-ylpiperidin-3-yl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-[3-[4-(trifluoromethyl)piperidin-1-yl]propyl]quinoxalin-6-amine;(3S)-1-[2-(3,5-dimethoxy-N-[3-(1H-pyrazol-4-yl)quinoxalin-6-yl]anilino)ethyl]pyrrolidine-3-carbonitrile is sourced from PubChem (CID 157188437), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).